In focus · trending topic

Al Altomari JNJ Drexel Insmed

6 stories · following the connections

Agile Therapeutics to Present at the Rodman & Renshaw 19th Annual Global Investment Conference

By Nasdaq OMXAug 22, 2017, 11:30 AM UTC

Agile Therapeutics to Present at Liolios 6th Annual Gateway Conference

By Nasdaq OMXAug 16, 2017, 8:10 PM UTC

Agile Therapeutics Reports Additional Phase 3 SECURE Study Results Relating to Twirla® at ACOG 2017

By Nasdaq OMXMay 6, 2017, 6:05 PM UTC

Agile Therapeutics Announces Presentation of SECURE Phase 3 Data at the 2017 Congress on Women’s Health

By Nasdaq OMXApr 27, 2017, 11:31 AM UTC

Agile Therapeutics to Present at Biotech Showcase 2017

By Nasdaq OMXDec 22, 2016, 1:00 PM UTC

Agile Therapeutics Reports Third Quarter 2016 Financial Results and Announces Completion of Subject Visits for Twirla® Phase 3 SECURE Clinical Trial

By Nasdaq OMXNov 7, 2016, 9:10 PM UTC